ijms-logo

Journal Browser

Journal Browser

Advances in Lung Cancer: From Genetic Landscape to Treatment

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 26 August 2025 | Viewed by 1548

Special Issue Editor


E-Mail Website
Guest Editor
Unit of Pathological Anatomy, University Hospital of Pisa, Via Roma 67, 56126 Pisa, Italy
Interests: molecular pathology; lung cancer; malignant pleural mesothelioma; precision medicine; predictive biomarkers; molecular tests; next generation sequencing

Special Issue Information

Dear Colleagues,

Precision medicine, including both targeted therapies and immunotherapy, has dramatically changed and improved the clinical practice of lung cancer. To date, different molecular targets have been approved for metastatic advanced non-small cell lung cancer, mainly adenocarcinoma histotype, and more recently also for early-stage tumors. The molecular characterization of targetable alterations is mandatory to assess the best therapeutic approaches. However, in most lung cancer cases, available biological material is scarce, mainly represented by small biopsies or cytological specimens. In this context, liquid biopsy, particularly circulating cell free tumor DNA, has recently acquired great value as a complement of tissue testing. In addition, molecular investigations of lung cancer are warranted to uncover and face resistance mechanisms to therapy, and identify new predictive biomarkers. Therefore, the continuous optimization of next-generation sequencing techniques is crucial for a complete molecular analysis, including a plethora of genetic alterations from gene mutations to gene fusions and gene expression profiling.

This Special Issue of the International Journal of Molecular Sciences welcomes original articles, case reports, reviews and metanalyses on the advances in lung cancer covering the genetic landscape to treatment.

We look forward to receiving your contributions.

Dr. Rossella Bruno
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lung cancer
  • precision medicine
  • predictive biomarkers
  • resistance mechanisms
  • targeted therapy
  • immunotherapy
  • molecular tests
  • liquid biopsy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

28 pages, 871 KiB  
Review
Cancer-Associated Fibroblasts as the “Architect” of the Lung Cancer Immune Microenvironment: Multidimensional Roles and Synergistic Regulation with Radiotherapy
by Zheng Shi, Cuilan Hu, Qiang Li and Chao Sun
Int. J. Mol. Sci. 2025, 26(7), 3234; https://doi.org/10.3390/ijms26073234 - 31 Mar 2025
Viewed by 939
Abstract
Cancer-associated fibroblasts (CAFs), as the “architect” of the immune microenvironment in lung cancer, play a multidimensional role in tumor progression and immune regulation. In this review, we summarize the heterogeneity of the origin and the molecular phenotype of CAFs in lung cancer, and [...] Read more.
Cancer-associated fibroblasts (CAFs), as the “architect” of the immune microenvironment in lung cancer, play a multidimensional role in tumor progression and immune regulation. In this review, we summarize the heterogeneity of the origin and the molecular phenotype of CAFs in lung cancer, and explore the complex interactions between CAFs and multiple components of the tumor microenvironment, including the regulatory relationships with innate immune cells (e.g., tumor-associated macrophages, tumor-associated neutrophils), adaptive immune cells (e.g., T cells), and extracellular matrix (ECM). CAFs significantly influence tumor progression and immunomodulation through the secretion of cytokines, remodeling of the ECM, and the regulation of immune cell function significantly affects the immune escape and treatment resistance of tumors. In addition, this review also deeply explored the synergistic regulatory relationship between CAF and radiotherapy, revealing the key role of CAF in radiotherapy-induced remodeling of the immune microenvironment, which provides a new perspective for optimizing the comprehensive treatment strategy of lung cancer. By comprehensively analyzing the multidimensional roles of CAF and its interaction with radiotherapy, this review aims to provide a theoretical basis for the precise regulation of the immune microenvironment and clinical treatment of lung cancer. Full article
(This article belongs to the Special Issue Advances in Lung Cancer: From Genetic Landscape to Treatment)
Show Figures

Figure 1

Back to TopTop